ASPE
ASPE
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
4
$68.00M
Insider Sales
0
$0
Total Volume
$68.00M
4 transactions
Net Activity
+$68.00M
Net buying
Sentiment Rating
Strong AccumulationCEO Conviction Index
No Recent Signal
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
- •Cluster buying: 4 unique insiders purchased shares, showing strong alignment.
- •Ultra-high accumulation: total purchase value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Arch Venture Fund X, L.P.
10%
$20.00M total
Arch Venture Partners Xiv, L.P.
10%
$18.00M total
Thompson Peter A.
Dir, 10%
$15.00M total
Orbimed Advisors LLC
Dir, 10%
$15.00M total
Quick Actions
ASPE has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%. ASPE ranks #27 in insider activity out of 569 tracked companies in its industry.
Over the last 90 days, corporate insiders at ASPE (ASPE) engaged in a total of 4 transactions reported via SEC Form 4 filings. Among these, 4 were open-market purchases and 0 were sales. The total volume of insider trading reached $68.00M.
The net insider activity for ASPE shows a net buying bias of $68.00M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Purchase by Arch Venture Fund X, L.P. (10%), who traded 1.33M shares valued at $20.00M on Nov 2, 2026.
symbol__ Stock Quote Price and Forecast
ASPE|Aspen Neuroscience Ord Shs|Price:12.390|Chg%:+0.380
Bispecific biotech Bambusa and Parkinson’s-focused Aspen slide on trading debuts
Aspen Neuroscience (ASPE) Stock News & Updates
Aspen Neuroscience, Inc. (ASPE) Stock Price: Nov 2 Close $13.04
Aspen Neuroscience (ASPE) Stock Chart and Price History 2026 $ASPE
FAQs About ASPE Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for ASPE.